Ultrasound Assessment of Airway Edema During Laparoscopic Cholecystectomy
Launched by ENGIN ÇETIN · Jun 13, 2025
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is investigating whether increased pressure in the abdomen during laparoscopic cholecystectomy, a type of surgery to remove the gallbladder, can lead to swelling in the airway. Researchers want to find out if this swelling, known as airway edema, could make it more challenging to breathe after the surgery. To do this, they will look at two groups of patients: one group will have low pressure in the abdomen during the surgery, while the other group will have standard pressure. They will use ultrasound to measure changes in the airway before and after the procedure.
To participate in this study, patients need to be between 18 and 65 years old, have a healthy body weight, and be scheduled for this specific surgery. However, individuals with certain health conditions, such as a history of breathing difficulties or severe heart and lung diseases, will not be eligible. Participants can expect to undergo routine monitoring and measurements during their surgery, and their results will help doctors understand more about the risks associated with airway swelling after surgery. This research aims to improve safety for patients undergoing laparoscopic cholecystectomy in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age between 18 and 65 years
- • ASA physical status I-II
- • Body mass index (BMI) \< 30 kg/m²
- • Mallampati score I-II
- • Scheduled for elective laparoscopic cholecystectomy
- Exclusion Criteria:
- • History of difficult intubation
- • Upper respiratory tract infection
- • Obstructive sleep apnea or STOP-Bang score ≥3
- • Severe cardiopulmonary disease
- • Pregnancy
- • Indication for emergency surgery
About Engin çetin
Engin Çetin is a dedicated clinical trial sponsor committed to advancing medical research and innovation. With a strong focus on developing novel therapies and improving patient outcomes, the organization collaborates with leading researchers and institutions to conduct rigorous clinical trials across various therapeutic areas. Engin Çetin prioritizes ethical practices, patient safety, and scientific integrity, ensuring that all studies are designed and executed to the highest standards. Through its strategic partnerships and commitment to excellence, Engin Çetin aims to contribute significantly to the advancement of healthcare and the discovery of transformative treatments.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Kocaeli̇, Izmit, Turkey
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported